These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. CD45 Mao FY; Zhao YL; Lv YP; Teng YS; Kong H; Liu YG; Wu XL; Hao CJ; Chen W; Duan MB; Han B; Ma Q; Wang TT; Peng LS; Zhang JY; Cheng P; Su CY; Fu XL; Zou QM; Guo G; Guo XL; Zhuang Y Cell Death Dis; 2018 Jul; 9(7):763. PubMed ID: 29988030 [TBL] [Abstract][Full Text] [Related]
4. CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells. Jitschin R; Saul D; Braun M; Tohumeken S; Völkl S; Kischel R; Lutteropp M; Dos Santos C; Mackensen A; Mougiakakos D J Immunother Cancer; 2018 Nov; 6(1):116. PubMed ID: 30396365 [TBL] [Abstract][Full Text] [Related]
6. CD33 Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700 [TBL] [Abstract][Full Text] [Related]
7. T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells. Azzaoui I; Uhel F; Rossille D; Pangault C; Dulong J; Le Priol J; Lamy T; Houot R; Le Gouill S; Cartron G; Godmer P; Bouabdallah K; Milpied N; Damaj G; Tarte K; Fest T; Roussel M Blood; 2016 Aug; 128(8):1081-92. PubMed ID: 27338100 [TBL] [Abstract][Full Text] [Related]
8. Expansion of monocytic myeloid-derived suppressor cells in endometriosis patients: A pilot study. Chen H; Qin S; Lei A; Li X; Gao Q; Dong J; Xiao Q; Zhou J Int Immunopharmacol; 2017 Jun; 47():150-158. PubMed ID: 28407569 [TBL] [Abstract][Full Text] [Related]
9. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer. Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521 [TBL] [Abstract][Full Text] [Related]
10. The roles of polymorphonuclear myeloid-derived suppressor cells in endometriosis. Satake E; Koga K; Takamura M; Izumi G; Elsherbini M; Taguchi A; Makabe T; Takeuchi A; Harada M; Hirata T; Hirota Y; Wada-Hiraike O; Osuga Y J Reprod Immunol; 2021 Nov; 148():103371. PubMed ID: 34517223 [TBL] [Abstract][Full Text] [Related]
11. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer. Li F; Zhao Y; Wei L; Li S; Liu J Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426 [TBL] [Abstract][Full Text] [Related]
12. Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function. Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Bossman SA; Ter Laan M; Wesseling P; Adema GJ Neuro Oncol; 2016 Sep; 18(9):1253-64. PubMed ID: 27006175 [TBL] [Abstract][Full Text] [Related]
13. The Frequency and Effect of Granulocytic Myeloid-Derived Suppressor Cells on Mycobacterial Survival in Patients With Tuberculosis: A Preliminary Report. Davids M; Pooran A; Smith L; Tomasicchio M; Dheda K Front Immunol; 2021; 12():676679. PubMed ID: 34149712 [TBL] [Abstract][Full Text] [Related]
14. TGF-β Enhances the Anti-inflammatory Effect of Tumor- Infiltrating CD33+11b+HLA-DR Myeloid-Derived Suppressor Cells in Gastric Cancer: A Possible Relation to MicroRNA-494. Moaaz M; Lotfy H; Elsherbini B; Motawea MA; Fadali G Asian Pac J Cancer Prev; 2020 Nov; 21(11):3393-3403. PubMed ID: 33247701 [TBL] [Abstract][Full Text] [Related]
15. Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma. Santegoets KCM; Gielen PR; Büll C; Schulte BM; Kers-Rebel ED; Küsters B; Bossman SAJFH; Ter Laan M; Wesseling P; Adema GJ Cancer Immunol Immunother; 2019 Jun; 68(6):937-949. PubMed ID: 30953118 [TBL] [Abstract][Full Text] [Related]